专利号:US-2006167025-A1 优先权日:2004-12-22 标 题:Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs 发明人:BERGER MARKUS; SCHMEES NORBERT; SCHAECKE HEIKE; BAURLE STEFAN; REHWINKEL HARTMUT; MENGEL ANNE; KROLIKIEWICZ KONRAD; GROSSBACH DANJA; VOIGTLAENDER DAVID 权利人:BERGER MARKUS; SCHMEES NORBERT; SCHAECKE HEIKE; BAURLE STEFAN; REHWINKEL HARTMUT; MENGEL ANNE; KROLIKIEWICZ KONRAD; GROSSBACH DANJA; VOIGTLAENDER DAVID 摘要:The invention relates to tricyclic amino alcohols of general formula (I) n nmethod for synthesis of same and use of same as anti-inflammatory agents.
专利号:WO-2018154596-A1 优先权日:2017-02-22 标 题 :Process for synthesis of tiotropium bromide monohydrate 发明人:REDDY G NITHUN; REDDY G SAMHITHA; REDDY G MADAALASA; RAMANI M; REDDY G PRATAP 权利人:GBR LABORATORIES PVT LTD; RACHANA PHARMA TECH 摘要:Provided herein is a process for synthesis of tiotropium bromide wherein the coupling of scopine with 2, 2-dithienyl glycolate is achieved by a two step process under mild conditions.
专利号:US-2025206743-A1 优先权日:2022-03-25 标 题:Tyk2 inhibitor synthesis and intermediates thereof 发明人:MASSE CRAIG E; PHADKE AVINASH S; LAWSON JON P; LEVY STUART; YANG XIAOWEI; WU GUISHENG; FAN SHUFENG 权利人:TAKEDA PHARMACEUTICALS CO 摘要:Described herein are methods of synthesis of a tyrosine-protein kinase 2 (TYK2) inhibitor and to intermediate compounds of the synthesis and methods of making the intermediates. Also provided are pharmaceutically acceptable compositions including compounds prepared by the synthetic method and methods of treating disorders using the same.
专利号:WO-2013046138-A1 优先权日:2011-09-27 标 题:Process for the preparation of scopine esters 发明人:CIPOLLONE AMALIA; FATTORI DANIELA; FINCHAM CHRISTOFER INGO 权利人:LUSOCHIMICA SPA 摘要:The present invention relates to a process for the preparation of scopine esters, as intermediates in the synthesis of tiotropium bromide. In particular, it relates to a transesterification process between scopine alcohol and an ester of a carboxyl acid in high yields and under conditions suitable for industrial use.
专利号:WO-2021133280-A1 优先权日:2019-12-27 标 题 :An improved process for preparation of scopine hydrobromide 发明人:HAAS PHILIPP DANIEL; STECKEL HARTWIG ANDREAS; BELLUR ATICI ESEN; AYDIN FATMA GÖZDE 权利人:DEVA HOLDING 摘要:The present invention relates to an efficient and industrially advantageous process for the preparation of scopine free base or salts. Said compounds are important intermediates in the synthesis of tiotropium and pharmaceutically acceptable salts thereof. The method provided for preparing scopine free base or its salts has the advantages of a simple operation, high yield and low costs.
专利号:WO-2018055642-A1 优先权日:2016-09-23 标 题:A process for preparing tiotropium bromide and intermediates thereof 发明人:REDDY G NITHUN; REDDY G SAMHITHA; REDDY G MADAALASA; RAMANI M; REDDY G PRATAP 权利人:GBR LABORATORIES PVT LTD; RACHANA PHARMA TECH 摘要:Provided herein is a process for synthesis of tiotropium bromide and a process for synthesis of scopine starting from a dimethyl tartarate compound. The synthetic sequence comprises a double Mannich reaction (Robinson-Schopf reaction).
参考文献:10.1186/2047-783x-14-s4-27 摘要:Beyer D, Mitfessel H, Gillissen A. Maternal smoking promotes chronic obstructive lung disease in the offspring as adults. European Journal of Medical Research. 2009 Dec 07;14(Suppl 4):27. doi: 10.1186/2047-783x-14-s4-27. 参考文献:10.1186/2047-783x-14-s4-205 摘要:Rantzsch U, Vacca G, Dück R, Gillissen A. Anti-inflammatory effects of myrtol standardized and other essential oils on alveolar macrophages from patients with chronic obstructive pulmonary disease. European Journal of Medical Research. 2009 Dec 07;14(Suppl 4):205. doi: 10.1186/2047-783x-14-s4-205. 参考文献:10.2165/11319010-000000000-00000 摘要:Johansson S, Wallander MA, de Abajo FJ, García Rodríguez LA. Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios. Drug Saf. 2010 Mar 01;33(3):223–32. doi: 10.2165/11319010-000000000-00000.